Literature DB >> 3997865

Heparin binding is necessary, but not sufficient, for fibronectin aggregation. A fluorescence polarization study.

K L Bentley, R J Klebe, R E Hurst, P M Horowitz.   

Abstract

Analysis of parameters governing heparin binding to fibronectin indicates that heparin binding is a necessary, but insufficient, condition for fibronectin cryoprecipitation. Heparin binding to fibronectin is a rapid, readily reversible event which can occur under several conditions which prohibit fibronectin cryoprecipitation. While cryoprecipitation of fibronectin is abolished at temperatures in excess of 10 degrees C, appreciable heparin binding to fibronectin does occur even at 40 degrees C. While increasing ionic strength and pH inhibit both heparin binding and cryoprecipitation of fibronectin, heparin binding can still occur at high ionic strengths and pH values which completely abolish cryoprecipitation. Scatchard analysis of fluorescent polarization data reveals a biphasic heparin binding curve with high and low affinity Kd values of 3.5 X 10(-8) and 10(-6) M, respectively. In contrast to heparin binding, fibronectin aggregation is a cooperative phenomenon. Fibronectin cryoprecipitation is greatly reduced at temperatures above 10 degrees C, at pH values above pH 10, and at ionic strengths above 0.3 M. Thus, heparin binding and protein aggregation are separate events which occur during fibronectin cryoprecipitation. Results obtained here via fluorescence polarization in conjunction with other physical measurements suggest that a decrease in flexibility of the fibronectin molecule is associated with the protein aggregation step of cryoprecipitation. The role of heparin in the mechanism of fibronectin cryoprecipitation is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3997865

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Crystal structure of a heparin- and integrin-binding segment of human fibronectin.

Authors:  A Sharma; J A Askari; M J Humphries; E Y Jones; D I Stuart
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Non-Watson-Crick interactions between PNA and DNA inhibit the ATPase activity of bacteriophage T4 Dda helicase.

Authors:  Alan J Tackett; David R Corey; Kevin D Raney
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

3.  Interaction of heparin with fibronectin and isolated fibronectin domains.

Authors:  K C Ingham; S A Brew; D H Atha
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

4.  Acceleration of wound healing by local application of fibronectin.

Authors:  G Scheel; B Rahfoth; J Franke; P Grau
Journal:  Arch Orthop Trauma Surg       Date:  1991       Impact factor: 3.067

5.  Structural domains of heparan sulphate for specific recognition of the C-terminal heparin-binding domain of human plasma fibronectin (HEPII).

Authors:  A Walker; J T Gallagher
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

6.  Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling.

Authors:  Cunji Gao; Brian Boylan; Juan Fang; David A Wilcox; Debra K Newman; Peter J Newman
Journal:  Blood       Date:  2011-03-02       Impact factor: 22.113

7.  Vascular binding of a pathogen under shear force through mechanistically distinct sequential interactions with host macromolecules.

Authors:  Tara J Moriarty; Meiqing Shi; Yi-Pin Lin; Rhodaba Ebady; Hong Zhou; Tanya Odisho; Pierre-Olivier Hardy; Aydan Salman-Dilgimen; Jing Wu; Eric H Weening; Jon T Skare; Paul Kubes; John Leong; George Chaconas
Journal:  Mol Microbiol       Date:  2012-10-24       Impact factor: 3.501

8.  Enhanced levels of attachment of fibronectin-primed Treponema pallidum to extracellular matrix.

Authors:  D D Thomas; J B Baseman; J F Alderete
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

9.  Estimation of a stronger heparin binding locus in fibronectin domain III14 using thermodynamics and molecular dynamics.

Authors:  Sakshi Gupta; Neha Tiwari; Jyoti Verma; Mohd Waseem; Naidu Subbarao; Manoj Munde
Journal:  RSC Adv       Date:  2020-05-27       Impact factor: 4.036

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.